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An oxidative stress in the form of H2O2 exposure previously has been shown to 
cause a transient increase in NO• production and a chronic increase in eNOS protein 
levels, presumably compensatory responses.  Nevertheless, oxidative stress can cause 
an uncoupling of catalytic activity resulting in decreased NO• and increased O2•- 
production from eNOS. This uncoupling seems to be mediated predominantly by 
oxidation of tetrahydrobiopterin (BH4), an eNOS required cofactor.  To study how these 
phenomena regulate the physiological balance of reactive oxygen species (ROS), H2O2-
induced NO• production was measured in endothelial cells using an NO• specific 
electrode.  Following H2O2 exposure, NO• concentrations initially increased; however, if 
cells were challenged a second time with H2O2, the increase in NO• production was 
attenuated.  We postulated that the decline in NO• production after H2O2 exposure 
resulted from BH4 oxidation.  This was tested by supplementing cells with BH4 just prior 
to the second H2O2 exposure.  BH4 supplementation prevented the decrement in NO• 
production after a second H2O2 exposure.   
Because H2O2 also activates NADPH oxidases, causing increased superoxide 
(O2•-) production, we then postulated that BH4 oxidation might be the result of a H2O2-
induced increase in O2•-.  This was tested by supplementing cell media with the O2•- 
scavenger, polyethelene glycol conjugated superoxide dismutase (PEG-SOD), or with 
the NADPH oxidase inhibitor, apocynin.  Results were supported with measurement of 
H2O2-induced NO• production in p47phox-knockout cells, which have genetically inhibited 
NADPH oxidase.  These manipulations, expected to reduce O2•-, resulted in a recovery 
of NO• production, consistent with the idea that O2•- produced by NADPH oxidase lead to 
the reduced eNOS function upon a second H2O2 exposure through oxidation of BH4.   
 xi 
Because peroxynitrite (ONOO-) and hydroxyl radicals (•OH) can be produced 
from O2•- and are more potent oxidizers of BH4, we tested whether either of these free 
radicals were involved in reduction of H2O2-induced NO• production with repetitive 
stimuli.  Scavenging ONOO- with uric acid resulted in a full recovery of NO• production, 
and scavenging •OH with mannitol resulted in a partial recovery of NO• production.  This 
suggested possible roles for both radicals in the reduction in H2O2-induced NO• release 
with multiple exposures.  
In summary, repeated exposures to H2O2 resulted in declines in induced NO• 
production in BAECs.  This reduction in the presumed compensatory NO• release could 
be attenuated by BH4 supplementation, by scavengers of O2•-, ONOO-, and •OH, and by 
inhibition of the NADPH oxidase system. Therefore, uncoupled eNOS as a result of BH4 
oxidation may explain the failure of compensatory NO• release to repeated oxidative 








1.1 The Importance of Oxidative Stress 
Oxidative stress has been shown to contribute to several cardiovascular 
diseases, including hypertension, atherosclerosis, diabetes, ischemia-reperfusion injury, 
heart failure, restenosis, atrial fibrillation, and hypercholesterolemia1, 2.  However, some 
oxidative stress, such as that produced in moderate exercise, is associated with 
decreased risk of cardiovascular disease3-5.  Here, we explore one possible explanation 
that might lead to failure of the compensatory mechanism to deal with increased 
oxidative stress and the associated progression of disease states. 
Many cardiovascular diseases are thought to be caused or perpetuated by an 
imbalance of reactive oxygen species (ROS), particularly superoxide (O2•-) and nitric 
oxide (NO•)2.  NO• is responsible for a wide range of beneficial cardiovascular functions, 
including vasodilation, decreased thrombosis formation, inhibition of fibroblast 
proliferation, reduced cell adhesion to endothelium, and increased myocardial lusitropy6.  
NO• is produced in endothelial cells primarily by endothelial nitric oxide synthase 
(eNOS).  Changes in endothelial cell NO• levels can be caused either by changes in 
NO• production or by NO· degradation, as happens when it reacts with O2•- to form 
peroxynitrite (ONOO-).   
 Efficient production of NO• by eNOS requires electron donation from the cofactor 
tetrahydrobiopterin (BH4).  If BH4 is oxidized, electron transfer in eNOS becomes 
uncoupled, and eNOS produces O2•- instead of NO•7.  This can have a significant effect 
on the bioavailability of NO•, since eNOS uncoupling reduces NO• production and might 
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increase NO• degradation by producing more O2•- 8.  Because BH4 can be oxidized easily 
by ROS prevalent in endothelial cells8, 9, it is possible that BH4 oxidation may be a 
feature of many cardiovascular disease states.   
 Hydrogen peroxide (H2O2) is the most stable and long-lasting ROS.  Therefore, it 
can act as a paracrine signaling molecule10.  H2O2 is known to activate both eNOS11 and 
O2•--producing NADPH oxidase10, so this membrane permeable ROS may be important 
in balancing the oxidative state of the cell.  Previously, we have shown that a single 
exposure to H2O2 activates eNOS11. In these experiments, we explore whether this effect 
is maintained with multiple H2O2 challenges or if continued oxidative stress diminishes 
the presumably compensatory NO• release.   
 
1.2 Specific Aims 
Although some oxidative stress, such as that experienced during moderate 
exercise, has been shown to be beneficial, larger amounts of oxidative stress are 
thought to contribute to the development of cardiovascular disease.  An understanding of 
this apparent paradox requires a deeper study of the delicate physiological balance 
between ROS, including O2•-, H2O2, •OH, NO•, and ONOO-.  The overall aim of this 
project is to study this balance by examining the effect of H2O2, the most stable and 
long-lasting ROS, on production of NO• in endothelial cells.   
Previous studies have shown that H2O2 causes an initial activation of endothelial 
nitric oxide synthase (eNOS)11.  Nevertheless, we observed that if cells are challenged a 
second time with H2O2, the increase in NO• production is attenuated.  The objective of 
this project was to determine the cause of NO• production attenuation after a second 
H2O2  exposure.  We tested the hypothesis that the decline might be the result of 
uncoupled eNOS occurring with oxidation of the essential eNOS cofactor 
tetrahydrobiopterin (BH4).  The project consisted of three specific aims:  (1) to determine 
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the role of BH4 oxidation in H2O2-induced NO• production decline, (2) to determine which 
oxidizing agents might contribute to eNOS dysfunction, and (3) to evaluate role of 











Electrochemical detection of nitric oxide (NO•) has certain advantageous 
characteristics including temporal resolution, spatial resolution, and sensitivity with a 
detection limit sufficient for biological samples12, 13.  In this technique, the voltage is 
controlled so that NO• oxidation is catalyzed on an electrode surface.  At a chosen 
sampling time and at a voltage above the redox potential of NO•, the current generated 
is a linear function of NO• concentration at the electrode surface. There are two common 
recording modes, cyclic voltammetry and amperometry.  In cyclic voltammetry, voltage is 
varied and current is measured.  This mode is best for identification of species, since the 
voltage corresponding to an increase in faradic current is determined by the half-cell 
potential specific to a particular chemical species (figure 2-1).  In amperometry, voltage 
is held constant above the oxidation potential, and current is measured.  This mode is 
used commonly to quantify species concentration. Electrodes are typically filaments 
made of carbon or platinum13, 14.  They are made more specific by coatings that either 





Figure 2-1:  Voltammetry showing faradic current generated by NO•. The dashed line 
shows current elicited by the voltage ramp in phosphate buffered saline (PBS) only.  
With NO• present in solution, an additional, faradic current representing the oxidation of 
NO• can be seen at voltages above ∼+750 mV relative to an AgCl reference electrode.  
  
Here, we describe procedures for measuring NO• from endothelial cells and 
cardiac tissue using a carbon fiber electrode coated with Nafion and o-
phenylenediamine (o-PD) exclusion coatings.  The use of these exclusionary coatings 
was first described by Friedemann, et al16.  Although other electrodes are available, 
even commercially, we have chosen this electrode because of its small tip size, ease of 
fabrication, reliability, and low cost. 
 
2.2 Electrode Fabrication and Characterization 
 Electrodes were fabricated as described previously16, with a few simplifications.  
Suitable Nafion-coated carbon electrodes (30 µm diameter and 100 µM exposed surface 
height) were purchased commercially (World Precision Instruments, Inc., Sarasota, FL). 
Electrode integrity was confirmed by voltage ramp protocols and by visual inspection 
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Figure 2-2:  Evaluating electrode integrity.  (A) Glass-encased, cylindrical carbon fiber 
electrode (30 µm x 100 µm exposed area).  (B) Current responses in PBS to voltage 
ramp protocols to test electrode properties.  High resistance electrodes are less 
sensitive to NO• and other oxidizable species.  Electrodes with broken tips have current 
responses that tend to increase more quickly at higher increasing voltages than current 
responses for unbroken electrodes exposed to the same voltage ramp protocol. 
 
After electrode integrity is confirmed, an additional o-phenylene diamine (o-PD) 
coating was applied to increase NO• specificity. o-PD was polymerized on the electrode 
surface at +900 mV in a stirred 5 mM o-PD solution at 37ºC for 45 min. The o-PD 
solution was made fresh by dissolving one tablet o-phenylenediamine dihydrochloride (3 
mg substrate/tablet, Sigma, St. Louis, MO) in 3.3 mL of 100 µM ascorbic acid in 0.1 M 
phosphate buffered saline (PBS).  Successful coating blocked ascorbic acid from the 
electrode, as is indicated by a significant decrease in current (from about 20 nA to 200 
pA).  After coating, the electrode was allowed to dry for about one minute, dipped in 
water, and then allowed to dry overnight.  Electrodes were stored at 4ºC and could be 
used for several weeks after coating.  Before each experiment, electrodes were hydrated 
by soaking in PBS for at least 1 hour to increase baseline electrical stability. 
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 This form of exclusionary coating resulted in electrodes that were relatively 
selective for NO• when compared with other biological species with oxidation potentials 
in this range, such as H2O2, O2•-, and ascorbic acid (table 2-1).  To increase 
measurement accuracy in cells and tissue, the NO• synthase inhibitor, Nω-Nitro-L-
arginine methyl ester  (L-NAME) was added during measurements, and the L-NAME 
suppressible current used to calculate the NO• concentration. 
 
Table 2-1:  Sensitivity of One Electrode to Various Oxidizable Species 
Species Electrode Sensitivity to 
Species (pA/nM) 
NO• Sensitivity: Species 
Sensitivity 
NO•  5.5x10-2 1 
Ascorbic Acid 5.0x10-4 9.1x10-3 
H2O2  1.7x10-3 3.1x10-2 
O2•- 7.0x10-4 1.3x10-2 
 
 
2.3 Electrode Data Acquisition and Analysis 
 To minimize mechanical vibrations that generate piezoelectric currents and 
ambient electrical noise detection, experiments were performed on a vibration isolation 
table and in a grounded Faraday cage.  Measurements were taken relative to an AgCl 
reference electrode, and further noise reduction was accomplished by low-pass filtering 
with a 2 Hz cutoff frequency.   
Because sensitivity of the electrode to NO• varied over time and between 
electrodes, each electrode was calibrated before each experiment.  This was done by 
using dilutions of a saturated NO• solution.  A stock solution of saturated NO• was 
produced by bubbling NO• gas through deionized water that had been deoxygenated 
using N2 bubbling for 30 min.  Immediately after saturation, a NO• solution at 20ºC has a 
concentration of 2 mM17.  In a sealed system on ice, the solution NO• concentration 
stabilized at 1.4 mM over a 20 min period. An expedient method of calibration was 
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developed that involved serial additions of increasing volumes of diluted NO• solution 
added to deoxygenated 37ºC 0.1 M PBS while the electrode voltage was held constant 
at a voltage exceeding the NO• oxidation potential of +700 mV relative to a AgCl 
reference electrode (figure 2-3).   
 
 
Figure 2-3: Electrode Calibration.  (A) Serial additions of a concentrated solution of NO• 
are added and current recorded to create a calibration curve.  (B) Using a cylindrical 
Nafion and o-PD coated carbon fiber electrode (30 µm x 100 µm exposed area) and a 
voltage of +900 mV, the detection limit is ∼10 nM, and the response is linear up to 4 µM.  
The sensitivity from this calibration curve is 0.095 pA/nM, with R2 = 0.996. 
 
 
2.4 Measuring NO• from Endothelial Cells 
NO• was originally known as endothelium derived relaxing factor18, 19, and it is 
frequently desirable to measure NO• released from cultured endothelial cells under a 
variety of conditions.  Electrodes are sufficiently sensitive to measure NO• from single 
endothelial cells15, but we have generally measured from cultured monolayers of 60-90% 
confluency.  To help minimize signal contamination, immediately prior to measurement, 
culture media was exchanged with warmed 0.1 M PBS (pH 7.4).  With the dish of cells 
placed in a temperature controller on an inverted microscope stage, the electrode was 
positioned carefully using a micromanipulator.  Baseline current measurements were 
made with the electrode voltage held at +900 mV and when the electrode was 5 µm 
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away from the cells.  The NO• concentration gradient falls off as a function of distance 
from the cells, so the electrode was placed at a consistent distance above the 
monolayer.  After positioning near cells, the current increase from baseline was 
recorded.  The L-NAME suppressible signal was taken as indicative of the NO• faradic 
current and was converted to a NO• concentration (see figure 3-1 in chapter 3). For most 
cell experiments, chemicals were added to cells to determine their effect on NO• 
production.  For each chemical, control experiments were performed to ensure that the 
chemical did not interfere with the faradic current. 
 
2.5 Measuring NO• from Cardiac Tissue 
Others and we have shown that in healthy heart, most NO• is produced by the 
endocardium20, 21.  Pathological states can alter endocardial NO• production. We 
attempted to measure endocardial NO• from pig or mouse hearts under various 
experimental conditions.  Harvested tissue was rinsed in oxygenated Krebs-HEPES 
buffer (in mmol/L, NaCl 99.01, KCl 4.69, CaCl2 1.87, MgSO4 1.20, K2HPO4 1.03, Na-
NHEPES 20, and D-glucose 11.1) and stored on ice.  Tissue showed no deterioration in 
NO• production under these conditions for several hours.   
In general, NO• measurements from tissue were similar to measurements from 
cultured cells.  Measurements were made at 37ºC from trimmed myocardial pieces 
secured with pins in silicone-coated dishes.  Several challenges made NO• 
measurements from tissue more difficult than measurements from cells.  The distance 
between the tissue and the electrode was more difficult to determine than in cells.  To 
position the electrode, tissue deformation was observed in a stereomicroscope. Then, 
the electrode was backed away from the tissue a fixed distance.  If the electrode was not 
precisely positioned above the tissue, piezoelectric currents developed due to carbon 
fiber bending. These were considerably larger than the true faradic current.  Finally, 
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spatial heterogeneity of NO• production was evident.  In the ventricular endocardium of 
mice, NO• production tended to increase toward the apex of the heart.  Variations over 
smaller regions were also noted.   Despite these difficulties, an L-NAME suppressible 
current could be measured from tissue (figure 2-4).  Nevertheless, the remainder of this 
thesis focused on measurements of NO• from endothelial cell cultures. 
 
Figure 2-4:  NO• signal from the endocardium is L-NAME suppressible.  The electrode 
was placed in Krebs-HEPES bath far from the tissue, and lowered onto the tissue, 
resulting in a piezoelectric current. Then, the electrode was removed a fixed distance 
from the tissue, the faradic current was measured, and the electrode was removed from 
proximity to the endocardial surface, resulting in the reduction of faradic current to 
baseline.  This procedure was repeated after the addition of L-NAME, showing that most 
of the faradic current from endocardial cells could be ascribed to NO•.  
 
2.6 Conclusion 
In conclusion, electrochemistry can be used to reliably measure NO• produced 
by endothelium or endocardium.  The method is desirable because of its spatial and 
temporal resolution.  We have developed methods for measuring NO• concentration in 
endothelial cells and cardiac tissue using Nafion and o-PD carbon fiber electrodes.  
These techniques can also be applied to other tissues, and alterations in the electrode 
design have allowed use of electrochemistry to detect other biologically relevant 
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An oxidative stress in the form of H2O2 exposure previously has been shown to 
cause a transient increase in NO• production and a chronic increase in eNOS protein 
levels.  Nevertheless, oxidative stress can cause an uncoupling of catalytic activity 
resulting in decreased NO• and increased O2•- production from eNOS. This uncoupling 
seems to be mediated predominantly by oxidation of tetrahydrobiopterin (BH4), an eNOS 
required cofactor.  To study how these phenomena regulate the physiological balance of 
reactive oxygen species (ROS), H2O2-induced NO• production was measured in bovine 
aortic endothelial cells (BAECs) using an NO• specific electrode.  Following H2O2 
exposure, NO• concentrations initially increased; however, if cells were challenged a 
second time with H2O2, the increase in NO• production was attenuated.  We postulated 
that the decline in NO• production after H2O2 exposure resulted from BH4 oxidation and 
tested this by supplementing cells with BH4 prior to the second H2O2 exposure.  This 
resulted in a recovery of NO• production.  Since H2O2 also activates NADPH oxidase to 
produce superoxide (O2•-), we tested whether the decrease in NO• production during the 
second H2O2 exposure could be explained by increased NADPH oxidase-dependent 
oxygen free radical production, including O2•-, peroxynitrite (ONOO-), and hydroxyl 
radicals (•OH).  A reduction in H2O2-induced NO• release was prevented in apocynin-
and PEG-SOD-treated cells and in p47phox-knockout mouse aortic endothelial cells 
(MAECS), which lack a critical subunit of the NADPH oxidase.  These results suggest 
 12 
that O2•- produced by NADPH oxidase leads to eNOS dysfunction.  Scavenging ONOO- 
resulted in a full recovery of NO• production, and scavenging •OH resulted in a partial 
recovery of NO• production.  This implies roles for these O2•- derivatives in the reduced 
NO• response to repeated H2O2 exposures.   
 
3.2 Background and Significance 
3.2.1 Oxidative Balance 
Oxidative stress has been shown to contribute to several cardiovascular 
diseases; however, some oxidative stress, such as that produced in moderate exercise, 
is associated with decreased risk of cardiovascular disease3-5.  One possible explanation 
for this apparent paradox is that a small amount of oxidative stress increases the 
oxidative buffering capacity of the body, while a larger amount overpowers the 
compensatory mechanism.  In these experiments, we explore one possible explanation 
for the failure of that compensatory mechanism. 
Many cardiovascular diseases are thought to be caused or perpetuated by an 
imbalance of reactive oxygen species (ROS), particularly superoxide (O2•-) and nitric 
oxide (NO•)2.  NO• is produced throughout the body by endothelial nitric oxide synthase 
(eNOS), neuronal nitric oxide synthase (nNOS) and inducible nitric oxide synthase 
(iNOS) and is responsible for a wide range of beneficial cardiovascular functions.  In the 
cardiovascular system under physiological conditions, NO• is produced primarily by 
eNOS.  O2•- is produced by xanthine oxidase, mitochondria, NADPH oxidase, 
cytochrome P450, cyclooxygenase, and uncoupled eNOS.  O2•- reacts quickly with NO• 
to form ONOO- or is dismutated by superoxide dismutase (SOD) to H2O224, 25. 
3.2.2 eNOS Structure and Function 
eNOS is a homodimeric enzyme, with each subunit containing an oxygenase 
domain, which binds heme, tetrahydrobiopterin (BH4), and L-arginine; a reductase 
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domain, which binds flavoproteins FAD, FMN, and NADPH; and a calmodulin (CaM)-
binding domain, which connects the oxygenase and reductase domains26.  NO• is 
produced when eNOS converts L-arginine to Nω-hydroxyl-L-arginine and then to L-
citrulline and NO•.  This involves a two-electron transfer to the eNOS heme.   
In order for eNOS to be activated, it must be optimally aligned for efficient 
electron transfer.  This requires conformational changes through binding of calcium-
dependent calmodulin (CaM) and through phosphorylation of several serines on 
eNOS27.  Serine phosphorylation occurs via two primary pathways:  phosphatidylinositol-
3-kinase (PI3K) activation of Akt28 or adenylate cyclase activation of protein kinase A 
(PKA) through production of cAMP29.  The Akt pathway can be activated by shear stress 
(via G proteins)30, vascular endothelial growth factor (VEGF)31, insulin-like growth 
factor30, sphingosine-1-phosphate32, estrogen33, and H2O211.  The PKA pathway can be 
activated by shear stress (via G proteins)30, VEGF30, and bradykinin34.  H2O2 also 
activates eNOS through phosphorylation by the MAP kinase kinase MEK/ERK1/2 
pathway11.  VEGF, estrogen, sphingosine-1-phosphate, and bradykinin simultaneously 
activate phospholipase C-γ, which facilitates Ca++ release from the endoplasmic 
reticulum, promoting binding of CaM to eNOS27 and increasing eNOS activation.   
The first of the two electrons required for NO• production is donated by an 
NADPH molecule and transferred via two flavin molecules (FAD and FMN) to the heme 
oxygen26.  The second electron can come from the reductase domain or from BH47.  A 
heme oxygen that has been activated by one electron is unstable; if another electron is 
not readily available, this oxygen can be released as O2•- 7.  Electron donation by BH4 is 
faster than donation by the reductase domain.  Therefore, if BH4 is oxidized or 
unavailable, eNOS tends to produce O2•- instead of NO•35.  This phenomena is referred 




 BH4 is involved not only in NO• production as a cofactor of nitric oxide synthases, 
but also in phenylalanine metabolism as a cofactor of phenylalanine hydroxylase37 and 
in neurotransmitter synthesis38.  BH4 is produced de novo from GTP by three enzymes:  
GTP cyclohydrolase I (GTPCH), 6-pyruvoyl-tetrahydrobiopterin synthase, and 
sepiapterin reductase39.  Production of the intermediate dihydroneopterin triphosphate 
by GTPCH is the rate limiting step, and much of the control of BH4 synthesis is thought 
to occur through GTPCH40.  GTPCH is transcriptionally controlled by interferon γ, tumor 
necrosis factor α, lipopolysaccharide, and insulin41.  GTPCH activation is controlled 
primarily by the GTPCH feedback regulatory protein (GFRP), which allows for negative 
feedback by BH442.  BH4 can also be produced via a “salvage” pathway, in which 
sepiapterin is converted with sepiapterin reductase to 7,8-dihydrobiopterin (BH2), which 
is then converted to BH4 with dihydrofolate reductase43.  Although production of 
sepiapterin in mammalian cells has not been well characterized, this pathway has been 
used in the lab to increase cellular BH4 levels8, 44. 
 In eNOS, BH4 donates an electron to become a protonated trihydrobiopterin 
cation (BH3•H+).  It is then reduced to BH4 again by an electron from the eNOS 
reductase domain.  Steady replacement of BH4 is therefore not necessary in endothelial 
cells, unless BH4 is depleted by oxidation41. 
BH4 can be oxidized by several ROS, including O2•-, ONOO- 8, and hydroxyl 
radicals (•OH)9, 45, all of which are prevalent in endothelial cells.  O2•- is produced in 
endothelial cells by NADPH oxidase, xanthine oxidase, uncoupled eNOS, mitochondria, 
cytochrome P450, and cyclooxygenase46, 47.  ONOO- comes from a reaction between 
NO• and O2•-, and ONOO- levels can increase in a cell due to an increase in NO• 
production, an increase in O2•- production, or a combination of the two.  Hydroxyl radicals 
(•OH) can come from several sources, including degradation of protonated ONOO-, the 
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Fenton reaction (Fe2+ + H2O2 ‡ Fe3+ + •OH + OH-), or in small amounts by the Haber-
Weiss reaction ([H2O2 + O2•- ‡ O2•- + OH- + •OH])46, 48, 49.   
3.2.4 NADPH Oxidases 
O2•-, ONOO-, and •OH are all formed when production of O2•- increases.  The 
NADPH oxidases are a major source of O2•- in endothelial cells24, 50.  The endothelial cell 
NADPH oxidases are composed of several subunits, including membrane proteins 
p22phox and gp91phox (or gp91phox-like proteins NOX1, NOX4, or NOX5), along with 
cytoplasmic proteins Rac, p40phox, p67phox, and p47phox 10, 50.  Activation of the NADPH 
oxidases is dependent on phosphorylation of p47phox, which allows binding of p47phox to 
the p22phox subunit51.  The NADPH oxidases are activated in a variety of ways, including 
by mechanical forces, hormones such as angiotensin II, and H2O210.  Apocynin is a 
specific NADPH oxidase inhibitor that works by preventing NADPH oxidase subunit 
assembly52. 
3.2.5 H2O2, eNOS, and NADPH Oxidases 
H2O2, most commonly produced when O2•- is dismutated by superoxide 
dismutase (SOD), is the most stable and long lasting of the reactive oxygen species.  It 
is likely to play a critical role in maintaining the balance between O2•- and NO•, since it 
has been shown to act as a signaling molecule for both NADPH oxidases and eNOS. 
H2O2 activates the NADPH oxidases by stimulating signaling protein c-Src, which 
phosphorylates the NADPH oxidase subunit p47phox, allowing p47phox to move to the cell 
membrane and bind to the p22phox subunit10.  H2O2 activation of NADPH oxidase 
provides a form of positive feedback—a small amount of O2•- is produced and 
dismutated to H2O2, which activates additional production of O2•-.   
H2O2 has been shown also to act as a signaling molecule for eNOS upregulation 
and activation.  Exposure of endothelial cells to H2O2 causes upregulation of eNOS after 
several hours53.  On a shorter time scale (several min), H2O2 activates eNOS through 
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phosphorylation11.  Both of these processes would seem to help maintain a 
compensated, balanced redox state in the face of increased oxidative stress.  However, 
continued exposure to H2O2 for an intermediate time period (30 min) causes an initial 
increase in NO• production followed by a decline in NO• production54, 55.  One 
mechanism of this decline in NO• production may be eNOS uncoupling in the continued 
presence of an oxidative stress.   
 
3.3 Materials and Methods 
3.3.1 Cell Culture 
Bovine aortic endothelial cells (BAECs) (Cell Systems, Kirkland, WA) were 
cultured on 0.05% gelatin using M199 media (Cellgro, Herndon, VA) containing 10% 
FCS (Hyclone, Logan, UT) and 1% of each of the following:  penicillin/streptomycin 
(Cellgro), MEM vitamins (Cellgro), L-glutamine (Invitrogen-Gibco, Carlsbad, CA), and 
MEM Amino Acids (Invitrogen-Gibco).  Experiments were performed at 37ºC on passage 
4 or 5 cells that were 60-90% confluent. 
p47phox-knockout and wild type mouse aortic endothelial cells (MAECs) were 
obtained from Dr. Hanjoong Jo.  Cells were isolated as described previously56 and 
cultured on 0.1% gelatin in DMEM (Invitrogen-Gibco) containing 1.25% MEM non-
essential amino acids (Invitrogen-Gibco), 12.5% FBS (Atlanta Biologicals), 2.5 U/mL 
heparin (Baxter, Deerfield, IL), and 2% endothelial cell growth serum (isolated from 
bovine brain extract).  Experiments were performed at 37ºC on passages 6-10 at 60-
90% confluency. 
3.3.2 NO• Measurement 
 NO• was measured using a carbon electrode coated for NO• selectivity with 
Nafion and o-phenylenediamine.  Nafion-coated carbon electrodes (100 µm exposed 
length x 30 µm diameter) were obtained commercially (World Precision Instruments, 
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Sarasota, FL) and coated with o-phenylenediamine as described previously16.  NO• was 
measured amperometrically against an AgCl reference electrode, with the voltage of the 
electrode held constant at +900 mV, above the oxidation potential of NO•.  After 
calibration with known concentrations of NO• (obtained by bubbling NO• through N2-
degassed deionized H2O to saturation), the electrode was carefully lowered to the cell 
surface using a micromanipulator, then backed away 5 µm.  To insure the faradic current 
represented only NO• current seen in the presence of the eNOS inhibitor, L-NAME (Nω-
Nitro-L-arginine methyl ester, 2 mM) was subtracted from the unprocessed current to 
give the L-NAME suppressible current.  All electrodes used showed linear calibration 
curves with R2 > 0.95. 
3.3.3 Cell Treatments 
Prior to experiments, cells were incubated in 60 µM BH4 for 10 min to 
compensate for BH4 deficiencies known to occur in the oxidized environment of the cell 
culture incubator57-59.  BH4 was made fresh daily and used within several hours.  After 
BH4 incubation, cells were rinsed with PBS (pH 7.4, 37°C) to prevent BH4 electrode 
interference.  With cells in PBS media, the electrode was lowered to 5 µm above the cell, 
and current was measured until a stable baseline was achieved.  Cells were then 
exposed to 50 µM H2O2, and the resulting increase in NO• production was measured for 
30 min (“H2O2 exposure 1”).  The same cells were rinsed again with PBS, and current 
was measured 5 µM above the cell until a stable baseline was achieved.  The cells were 
again exposed to 50 µM H2O2 as the increase in NO• production was measured for 30 
min (“H2O2 exposure 2”).  
To determine possible mediators of the NO• production decrease upon H2O2 
exposure 2, cells were pre-incubated for 30 min with apocynin (600 µM), O2•- scavenger 
PEG-SOD (450 U/mL), ONOO- scavenger uric acid (100 µM), or •OH scavenger 
mannitol (3 mM) prior to the initial 10-minute BH4 incubation.  To maximize their effects 
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but prevent any faradic contamination when measuring NO•, uric acid, mannitol, and 
apocynin treatments were extended into H2O2 exposure 1 but not H2O2 exposure 2.  All 
chemicals were obtained from Sigma Chemicals (St. Louis, MO) unless otherwise noted. 
3.3.4 Data Analysis 
Data was obtained and analyzed using pClamp 8.0 (Axon Instruments, Union 
City, CA).  Unprocessed currents were low-pass filtered using an 8-pole Bessel filter with 
cutoff frequency of 2 Hz.  Statistical analysis was performed using Microsoft Excel 
(Redmond, WA) and Graphpad Prism (Graphpad Software, Inc., San Diego, CA).  NO• 
production as a function of time in response to H2O2 was compared using two-way 
ANOVAs.  Integrated NO• concentrations were compared using one-way ANOVAs or t 
tests with corrections for multiple comparisons as appropriate.  A p<0.05 was considered 
to be statistically significant.  All values are reported as mean ± SEM. 
 
3.4 Results 
3.4.1 NO• Production in Response to H2O2 
The majority of the faradic current measured from BAECs after H2O2 exposure 
appeared to be eNOS-dependent NO• release.  After BH4 supplementation to insure 
complete eNOS loading in all experiments, BAECs showed an increase in faradic 
current in response to 50 µM H2O2 exposure.  Most of the faradic current was 
suppressible by 2 mM L-NAME, suggesting that this signal was the result of NO• 
production (figure 3-1).  In subsequent experiments, the L-NAME suppressible signal 




Figure 3-1:  Determination of NO• concentration from the L-NAME suppressible faradic 
current. Panel A: Electrode responses to H2O2 in the presence and absence of the NOS 
inhibitor, L-NAME.  The electrode is around 50 times more sensitive to NO• than H2O2, 
but the difference in concentrations results in a minimal faradic current in response to 
H2O2.   Control experiments were performed by measuring current detected by the 
electrode upon addition to 50 µM H2O2 to BAECs preincubated for 10 min with 60 µM 
BH4 (n=9). L-NAME experiments were performed by measuring current detected by the 
electrode in the presence of 2 mM L-NAME upon addition of 50 µM H2O2 to BAECs 
(n=11).   Panel B: Seventy-nine percent of the integrated faradic current is suppressible 
by L-NAME. All subsequent results are reported as the L-NAME suppressible signal.  
 
BAECs showed a reduction in NO• release upon a second exposure to H2O2. 
Cells exposed to 50 µM H2O2 following preincubation with 60 µM BH4 (H2O2 exposure 1) 
increased NO• production after 10 min to 356 ± 94 nM (mean ± SEM, n=9).  After 30 
min, the NO• concentration decreased to 183 ± 51 nM.  As an index of the total amount 
of NO• produced by cells, the integrated NO• signal over 30 min was 11261 ± 2193 
nM·min.  After cells were rinsed in PBS, they were again exposed to 50 µM H2O2 (H2O2 
exposure 2).  The amount of NO• produced during H2O2 exposure 2 was less than that 
produced during H2O2 exposure 1.  During H2O2 exposure 2, NO• increased to 154 ± 49 
nM (n=9) by 10 min and then declined to 109 ± 35 nM at 30 min and was significantly 
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reduced from that seen with H2O2 exposure 1 (p<0.05). The integrated NO• production 
over 30 min was 5402 ± 1109 nM·min, significantly reduced from the first exposure 
(p<0.05, figure 3-2).       
 
 
Figure 3-2:  NO• induction by H2O2 is attenuated with multiple exposures. Panel A: Cells 
were incubated in 60 µM BH4 for 10 min prior to experiments to compensate for BH4 
oxidation in cell culture. Following addition of 50 µM H2O2 to BAECs, NO• production 
increases (n=9).  Subsequent addition of 50 µM H2O2 following PBS rinsing causes 
statistically smaller increases in NO• production (n=9; p<0.05).  Panel B: Integrated NO• 
production over time, an index of total NO• produced, is statistically reduced during the 
second exposure to H2O2 as compared to the first exposure (p<0.05). 
 
The decline in H2O2-mediated NO• release from BAECs was mitigated by 
addition of BH4.  Supplementing cells with 60 µM BH4 prior to H2O2 exposure 2 
prevented the decrease in NO• production (figure 3-3).  Following a second 
supplementation, the H2O2 exposure 2-induced NO• concentration increased after 10 
min to 407 ± 77 nM and declined by 30 min to 225 ± 53 nM.  Integrated NO• production 
over 30 min was 11164 ± 1990 nM·min (n=4).  Comparing either the time courses of NO• 
production or the integrated NO• values indicated that total NO• production from cells 
supplemented with BH4 just prior to H2O2 exposure 2 was not statistically different from 
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NO• production during H2O2 exposure 1 (p=0.4 and p=0.7, respectively). The restoration 
of NO• production in response to a second application of H2O2 by BH4 supplementation 
suggested that BH4 oxidation may be responsible for the loss of eNOS synthetic function 
after repeated oxidant exposures.   
 
Figure 3-3:  BH4 prevents eNOS dysfunction upon multiple H2O2 exposures. Panel A: 
Replenishing BAECs with 60 µM BH4 for 10 min prior to rechallenging cells with 50 µM 
H2O2 prevents the reduction in H2O2-induced NO• production seen with a second 
exposure to this ROS. In the case of BH4 supplementation between exposures, the first 
and second NO• production responses to H2O2 are similar (p=0.4).  Panel B: Integrated 
NO• production after exposure to H2O2 is statistically equivalent when cells are treated 
with BH4 (1st exposure, n=9; 2nd exposure, n=4; p=0.7). 
 
3.4.2 O2•- Scavenging Prevents the Loss of NO• Production with Repeated Exposures 
to H2O2  
 
We tested the possibility that O2•- might contribute to eNOS dysfunction by using 
the cell permeable O2•- scavenger, PEG-SOD.  Treating cells with PEG-SOD prevented 
the decreased NO• production seen during H2O2 exposure 2.  The peak increase in NO• 
upon a second exposure to H2O2 after cells were incubated with PEG-SOD was 518 ± 
91 nM at 10 min, and the NO• concentration declined to 400 ± 81 nM after 30 min.  This 
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resulted in an integrated NO• production of 15662 ± 2754 nM·min (n=4) (figure 3-4).  
This NO• production after a second exposure to H2O2 in PEG-SOD-treated cells was 
statistically improved when compared to a second exposure response in the absence of 
treatment (p<0.01) and was similar to that seen with a second BH4 supplementation 
treatment (p=0.23). This result suggested that O2•- was causing the resultant eNOS 
dysfunction after repeat exposures to H2O2, perhaps through BH4 oxidation. 
Because NADPH oxidases are activated by H2O2 and produce O2•- 50, we 
hypothesized that their increased activity may be responsible for the eNOS dysfunction 
seen on the second H2O2 exposure.  Suggesting this is the case, inhibiting NADPH 
oxidase assembly with apocynin (600 µM) prevented the eNOS dysfunction.  Upon H2O2 
exposure 2, apocynin-treated cells produced 352 ± 119 nM NO• at 10 min that declined 
slightly by 30 min to 318 ± 78 nM (n=4).  Integrated NO• over 30 min was 11003 ± 2406 
nM·min.  A comparison of integrated NO• values indicated that the integrated NO• 
produced by apocynin was statistically different from control (p<0.05), and that apocynin, 
BH4, and PEG-SOD treatments resulted in indistinguishable salvage of NO• production 





Figure 3-4:  Superoxide scavenging and NADPH oxidase inhibition prevent a decrease 
in NO• production after multiple H2O2 additions.  Panel A:  Time course of treatments 
with BH4 (60 µM), PEG-SOD (450 U/mL), apocynin (600 µM), and H2O2 (50 µM).  Panel 
B:  Comparison of NO• production during H2O2 exposure 2 with control (n=9, purple 
squares), BH4 (n=4, blue diamonds), PEG-SOD (n=4, green triangles), and apocynin 
(n=4, aqua circles) treatments. Panel C:  Integrated NO• production over 30 min.  BH4, 
PEG-SOD, and apocynin treatments were statistically different from control (* = p<0.05,  




 To support results seen with chemical inhibition of NADPH oxidase, we repeated 
experiments in aortic endothelial cells isolated from p47phox-knockout mice, lacking a 
critical subunit of the NADPH oxidase.  Although there was a significant difference 
between H2O2 exposure 1 and H2O2 exposure 2 integrated NO• production in wild-type 
MAECs (p<0.05), NO• production was similar during both H2O2 exposures in p47phox-
knockout cells (p=0.7).  In wild type cells, NO• production increased during H2O2 
exposure 1 to 342±78 nM at 10 min and declined to 275±56 nM at 30 min, for an 
integrated NO• production of 10729±2075 nM·min (n=5).  During H2O2 exposure 2, NO• 
production increased to 189±54 nM and declined to 110±22 nM after 30 min, and 
integrated NO• production over 30 min was 5135±1009 nM·min (n=9).  This represented 
a 2.1 fold decrease in total NO• production during the second exposure.  In p47phox-
knockout cells, NO• production increased to 409±182 at 10 min and decreased to 
284±80 nM at 30 min during H2O2 exposure 1.  Integrated NO• production over 30 min 
was 11568±1965 nM·min (n=4).  A second challenge with H2O2 caused a similar 
increase to 435±128 nM at 10 min and 252±70 nM at 30 min, with an integrated NO• 
production of 10283±3208 (n=3) (figure 3-5), eliminating the reduction in NO• production 
seen in the wild type cells.   
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Figure 3-5:  eNOS dysfunction with multiple H2O2 exposures is decreased in p47phox-
knockout MAECs.  Panel A:  Time course of NO• production in wild type (black 
diamonds) and p47phox-knockout (white squares) MAECs in response to 50 µM H2O2 
after preincubation for 10 min with 60 µM BH4.  NO• production during subsequent H2O2 
exposures was statistically different in wild type cells (n=5 for H2O2 exposure 1, n=9 for 
H2O2 exposure 2, p<0.05) but not in knockout cells (n=4 for H2O2 exposure 1, n=3 for 
H2O2 exposure, 2, p=0.9).  Panel B:  Integrated NO• production over 30 min in wild type 
and p47phox-knockout  MAECs (H2O2 exposure 1, light purple, H2O2 exposure 2, dark 
purple).  Integrated NO• production was statistically different in subsequent H2O2 
exposures to wild type cells (* = p<0.05) but not in knockout cells (p=0.7).   
 
3.4.3 ROS Scavengers Prevent the Loss of NO• Production with Repeated Exposures 
to H2O2   
 
Production of O2•- also increases cellular levels of ONOO- and •OH, since ONOO- 
forms by reaction of O2•- with NO•, and •OH forms by degradation of protonated ONOO- 
or through the Haber-Weiss reaction46, 49.  BH4 is thought to be preferentially oxidized by 
these free radical species in comparison to O2•-8.  We sought to determine whether these 
species were playing a role in the reduced eNOS function seen with repeated H2O2 
exposures. Treating cells with ONOO- scavenger, uric acid caused NO• production 
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during H2O2 exposure 2 to increase to 474 ± 96 nM by 10 min with a decline to 222 ± 43 
nM by 30 min. The integrated NO• production was 11030 ± 2356 nM·min (n=4) (figure 3-
6).  This was statistically indistinguishable from the effect of BH4 (p=0.65).  Treating cells 
with the •OH scavenger, mannitol, had an intermediate effect, causing NO• production 
during H2O2 exposure 2 to increase at 10 min to 271±73 nM and to decrease by 30 min 
to 235±42 nM.  The integrated NO• concentration with mannitol preincubation was 
8250±1236 nM·min.  The effect of mannitol was statistically indistinguishable from the 
control (p>0.05).  However, the trend in NO• production suggested a partial recovery in 




Figure 3-6:  ONOO- and •OH  scavengers preserve NO• production after multiple H2O2 
additions.  Panel A: Time course of treatments with ONOO- scavenger uric acid (100 
µM), •OH scavenger mannitol (3 mM), and H2O2 (50µM).  Panel B: Uric acid prevents the 
reduction in NO• production during H2O2 exposure 2, while mannitol partially recovers 
NO• production during H2O2 exposure 2.  The time courses of NO• production during 
H2O2 exposure 2 for control (purple squares, n=9), BH4 (blue diamonds, n=4), urate (red 
circles, n=4), and mannitol (orange triangles, n=6) are shown.  Panel C: Integrated NO• 
production over 30 min during H2O2 exposure 2 indicates that BH4, uric acid, and 
mannitol improve NO• bioavailability when compared to control cells.  Uric acid treatment 
resulted in a statistically significant improvement from control (* = p<0.05) that was 
indistinguishable from that of BH4 (p=0.65), suggesting that the decrease in NO• 
bioavailability on second exposure in the control case could be explained by ONOO-- 
mediated oxidation of BH4 to create uncoupled eNOS.  Mannitol resulted in a partial 




Many disease states are associated with decreased NO• and increased oxidative 
stress, yet exposure to moderate levels of oxidative stress induces increased NO• 
production and production capacity11, 53, presumably compensatory mechanisms.  
Therefore, it seems likely that some failure of these mechanisms is associated with the 
progression of disease.  One possible mechanism that could explain the transition from 
compensated to uncompensated states is eNOS uncoupling.  In this case, eNOS 
recruited by moderate levels of oxidative stress would actually contribute to generation 
of ROS by transferring electrons to molecular oxygen to produce O2•- rather than to L-
arginine to produce NO•.  Here, we show that addition of H2O2 to BAECs caused an 
initial increase in NO•.  Rechallenging with H2O2 caused the increase in NO• production 
to be attenuated.  The decline in H2O2-induced NO• production could be mitigated with 
BH4 supplementation, suggesting BH4 oxidation and subsequent uncoupling of eNOS 
may play a role in the attenuation of the response to H2O2. 
By itself, H2O2 is not very effective at oxidizing BH48, 9.  On the other hand, H2O2 
activates not only eNOS but also O2•--producing NADPH oxidase10.  Furthermore, 
increased NADPH oxidase activity is associated with hypertension and progression of 
atherosclerosis, suggesting that this enzyme may be part of the pathogenic cascade that 
leads to uncompensated oxidative stress in these diseases11.  Therefore, we tested 
whether the effect of repeat challenges by H2O2 could be mediated by the NADPH 
oxidase and its product, O2•-.  Genetic inhibition of NADPH oxidase in p47phox-knockout 
cells resulted in NO• production that was similar during both H2O2 exposures (p=0.7).  
Inhibition of NADPH oxidases by apocynin resulted in a recovery of H2O2-induced NO• 
production to the level seen with BH4 supplementation (p=0.96).  Scavenging O2•- with 
PEG-SOD had an effect that was statistically indistinguishable from apocynin (p=0.25), 
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although mean NO• production in cells treated with PEG-SOD was higher than in cells 
treated with apocynin.  This trend toward increased NO• in PEG-SOD treated cells could 
be explained if additional protection from oxidative degradation of NO• was provided by 
scavenging oxygen radicals from other sources such as xanthine oxidase, 
cyclooxygenase, cytochrome P450, and mitochondria.  Nevertheless, the majority of 
PEG-SOD effect could be attributed to NADPH oxidase produced O2•-. 
Although O2•- can oxidize BH4, ONOO- and •OH are known to be more potent 
BH4 oxidizers8, 9, 45.  Because ONOO- is formed when O2•- and NO• react, scavenging of 
O2•- would indirectly prevent BH4 oxidation by ONOO-.  Since uric acid scavenging 
resulted in NO• production statistically similar to that if cells were supplemented a 
second time with BH4 (p=0.97), the most parsimonious interpretation is that much of the 
eNOS dysfunction is mediated by the O2•- downstream product, ONOO-.  Scavenging of 
•OH with mannitol resulted in a partial recovery of NO• production, suggesting it is less 
important in the overall effect.  This could be because •OH is less prevalent in 
endothelial cells than ONOO-.  While there are other possible explanations for the effects 
of oxygen radicals on eNOS60, 61, the similarity of BH4 supplementation with the effects of 
PEG-SOD, apocynin, and urate, suggests that uncoupling of eNOS by BH4 oxidation is 
sufficient to explain the observed reduction in NO• produced with repeat H2O2 
exposures. 
BH4 oxidation in response to H2O2 may be part of the explanation of the failure of 
oxidative stress compensatory mechanisms.  H2O2 causes an increase in eNOS 
production53; however, if BH4 is oxidized, this eNOS may become uncoupled and could 
contribute to the production of O2•- 36.  This effect could be counterbalanced by H2O2-
induced BH4 production by GTPCH9, but GTPCH expression has been shown to be 
decreased in cardiovascular disease states such as diabetes, hypertension, and 
cardiomyopathy62-64.  Although the mechanism behind this downregulation remains 
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unclear, increased BH4 oxidation coupled with decreased BH4 production would 
significantly contribute to the disease state.  Therefore, preservation of BH4 by 
preventing its oxidation could help to maintain the oxidative stress balance and slow the 
progression of cardiovascular disease. 
Although a direct connection between cell culture and clinical importance is 
difficult to make, these results suggest two potential clinical treatments that could be 
used to preserve eNOS function: BH4 supplementation and NADPH oxidase inhibition.  
Oral BH4 has been used as a treatment for mild phenylketonuria in humans65, 66 and has 
successfully lowered blood pressure in hypertensive mice36.  The success of NADPH 
oxidase inhibition in restoring H2O2-induced NO• production is also promising, since 
NADPH oxidases can be pharmacologically inhibited.  Two classes of drugs, statins and 
angiotensin receptor agonists, have been found to inhibit NADPH oxidase.  The actions 
of these drugs are not specific for NADPH oxidase inhibition.  For example, statins can 
also activate cytochrome P450, which produces O2•- 24, potentially decreasing the NO• 
recovery effect.  On the other hand, statins have also been shown to increase production 
of GTP cyclohydrolase I67, potentially adding to positive NO• recovery effects.  Apocynin, 
a specific inhibitor of NADPH oxidase, has been used in clinical trials in the 
Netherlands68 and in herbal medicine69.  A better understanding of the way NADPH 
oxidases affect NO• production may reveal additional uses for these drugs.   
3.6 Conclusion 
Although H2O2 causes an initial increase in NO• production, NO• levels decline 
with additional exposures to H2O2.  The decline can be prevented by BH4 
supplementation, scavengers of ROS, and NADPH oxidase inhibition.  The similarity of 
these effects suggests that eNOS dysfunction to repeat H2O2 exposures can be 









 These studies also included many experiments that were not included in the 
previous chapters because they are preliminary in nature or the results are incompletely 
understood.  They are included here because they represent promising future lines of 
investigation. 
 
4.2 Possible Role of Dihydrobiopterin in NO• Recovery 
As a control experiment, the BH4 supplementation experiments in chapter 3 were 
repeated, replacing the second BH4 supplementation with the more oxidized BH2 to test 
whether in the presence of the more oxidized BH2, the BAEC NO• production would be 
similar to that in unsupplemented cells.  BAECs were cultured as before and incubated 
for 10 min in 60 µM BH4, rinsed with PBS, and exposed to 50 µM H2O2.  Cells were 
rinsed with PBS and then incubated for 10 min in 60 µM BH2 before again being 
exposed to 50 µM H2O2.  Surprisingly, BH2 supplementation resulted in partial recovery 
of NO• release during H2O2 exposure 2 (figure 4-1).  The easiest explanations for this 
result are that BH2 is being converted to BH4 by dihydrofolate reductase41 or that BH2 
can act as a oxygen radical scavenger.  It may be interesting to study this pathway 
further to determine why oxidized BH4 cannot be adequately replenished via the salvage 
pathway under our experimental conditions.  Perhaps more oxidized biopterin would be 
a better control.  Some groups have used (6S)-5,6,7,8-tetrahydro-L-biopterin, the 
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stereoisomer of the cofactor (6R)-5,6,7,8-tetrahydro-L-biopterin as a control70.  The two 
have the same reducing power, but the S stereoisomer cannot function as a cofactor. 
 
Figure 4-1:  Treating cells with BH2 results in a partial recovery of NO• production.  Panel 
A:  Time course for cell treatments BH4 (60 µM), BH2 (60 µM), and H2O2 (50 µM).  Panel 
B:  Comparison of NO• production during H2O2 exposure 2.  Time courses for control 
(n=9, purple squares), BH4 (n=4, blue diamonds), and BH2 (n=5, brown circles) are 
shown.  Panel C:  Integrated NO• production over 30 min during H2O2 exposure 2 
indicates that BH2 results in a partial recovery of NO• (p>0.05 as compared to control), 
suggesting involvement of the ‘salvage’ pathway of BH4 production or BH2 acting as an 
oxygen radical scavenger.   
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4.3 Measuring NO• from Cardiac Tissue 
 As discussed in chapter 2, NO• can be measured electrochemically from cardiac 
tissue.  Multiple attempts were made to measure NO• from the endocardium of hearts 
excised from pigs with atrial fibrillation (rapid pacing model) and mice with hypertension 
(DOCA salt model).   
Preliminary data comparing NO• production in the hearts of control mice and 
DOCA hypertensive mice showed a decrease in NO• production in DOCA hearts.  This 
corresponds well to work by Landmesser et al., in which DOCA mice fed 
tetrahydrobiopterin had improved endothelial function and decreased blood pressure36. 
Because of spatial variability noted in chapter 2, it might prove more convenient to use 
larger electrodes in this study.  This would increase the NO• signal and reduce 
experimental variability because of microheterogeneity. Continuing experiments begun 
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